Volume | 60,000 |
|
|||||
News | - | ||||||
Day High | 0.0198 | Low High |
|||||
Day Low | 0.0186 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
SANUWAVE Health Inc (QB) | SNWV | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.0198 | 0.0186 | 0.0198 | 0.0185 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
2 | 60,000 | US$ 0.01885 | US$ 1,131 | - | 0.0046 - 0.0298 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
08:39:17 | 47,500 | US$ 0.0186 | USD |
SANUWAVE Health Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
20.52M | 561.64M | 319.53M | 20.4M | -25.81M | -0.03 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
SANUWAVE Health (QB) News
Date | Time | Source | News Article |
---|---|---|---|
5/10/2024 | 06:16 | Edgar (US Regulatory) | Form 8-K - Current report |
5/09/2024 | 15:54 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2/28/2024 | 16:03 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business.. |
2/21/2024 | 15:07 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business.. |
2/21/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
2/05/2024 | 05:09 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
1/25/2024 | 16:17 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business.. |
1/25/2024 | 15:46 | Edgar (US Regulatory) | Form 8-K - Current report |
1/22/2024 | 15:45 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business.. |
1/10/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
1/03/2024 | 16:21 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business.. |
1/03/2024 | 16:17 | Edgar (US Regulatory) | Form 8-K - Current report |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SNWV Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.02 | 0.0228 | 0.0185 | 0.0199538 | 313,938 | -0.0014 | -7.00% |
1 Month | 0.0212 | 0.025 | 0.018 | 0.0210831 | 450,403 | -0.0026 | -12.26% |
3 Months | 0.025 | 0.0298 | 0.0114 | 0.0211442 | 392,543 | -0.0064 | -25.60% |
6 Months | 0.01455 | 0.0298 | 0.0046 | 0.0165852 | 529,887 | 0.00405 | 27.84% |
1 Year | 0.019 | 0.0298 | 0.0046 | 0.01661 | 430,839 | -0.0004 | -2.11% |
3 Years | 0.151 | 0.22 | 0.0001 | 0.057222 | 347,678 | -0.1324 | -87.68% |
5 Years | 0.16425 | 0.319 | 0.0001 | 0.1104183 | 332,205 | -0.14565 | -88.68% |
SANUWAVE Health (QB) Description
SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE's portfolio of products and product candidates activate biologic signaling and angiogenic responses, including revascularization and microcirculatory improvement, helping restore the body's normal healing processes and regeneration. SANUWAVE is applying its Pulsed Acoustic Cellular Expression (PACE) technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions. |